Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01396837 · ClinicalTrials.gov registry record · Phase 2
Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.
A Phase 2 study, sponsored by RedDress.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT01396837 is a Phase 2 study that has completed, run by RedDress. The registered enrollment target is 20 participants.
The verdict
NCT01396837, a Phase 2 study, has completed, sponsored by RedDress.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety of the RedDress Wound Care System (RD1) in patients Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.
Interventions
- DEVICE RedDress Wound Care System (RD1)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-05 |
| Est. Completion | 2017-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01396837
The ClinicalTrials.gov registry entry for NCT01396837 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RedDress, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RedDress Wound Care System (RD1) is the first listed.
NCT01396837 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01396837 about?
NCT01396837 is a clinical study titled "Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.". The purpose of this study is to assess the safety of the RedDress Wound Care System (RD1) in patients Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.
What is the current status of trial NCT01396837?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2014-05. Estimated completion is 2017-03.
What interventions are being tested in trial NCT01396837?
The interventions under investigation include: RedDress Wound Care System (RD1) (DEVICE).
Who is sponsoring clinical trial NCT01396837?
This trial is sponsored by RedDress, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.